Trump DOJ Demands Pause On Another Lawsuit Challenging FDA’s Abortion Pill Permissions
1 Trending: ‘Round River’ FBI Op Was A Deep State Conspiracy To Thwart Investigation Into Biden Family Corruption
2 Trending: Hegseth Orders Task Force To Probe DEI Indoctrination At America’s War Colleges
3 Trending: The Crisis In The Strait Of Hormuz Is Worse Because Of Dems’ Disastrous Energy Policy
4 Trending: Trump Needs To Prepare Americans For What Comes Next In Iran
Trump DOJ Demands Pause On Another Lawsuit Challenging FDA’s Abortion Pill Permissions
This is not the first time the Trump administration has moved to pause or dismiss pro-life states’ pleas for legal intervention.
Share Article on Facebook
Share Article on Twitter
Share Article on Truth Social
Share Article via Email
The Trump administration Department of Justice says women and babies whose lives and safety are threatened by popular abortion pills should have to wait until after U.S. Food and Drug Administration’s review of the popular abortion drug mifepristone to get relief.
The DOJ is redirecting its demands for a court-mandated pause on abortion pill lawsuits from the landmark Louisiana v. FDA case to take aim at Texas and Florida for challenging the FDA’s 2000 approval of mifepristone and subsequent expansions. It is under the Biden administration’s 2023 radical mifepristone permissions that anyone in any state can order mail-order pregnancy-ending pills and complete at-home abortions without medical oversight.
In its memorandum filed on Friday, the DOJ demanded the court “stay this litigation pending the outcome of FDA’s review” or........
